Original Research
Published on 22 Sep 2023
Extracellular vesicles as biomarkers for AIDS-associated non-Hodgkin lymphoma risk
Frontiers in Immunology
doi 10.3389/fimmu.2023.1259007
- 479 views
Type at least 3 characters
975 articles
Articles
Original Research
Published on 22 Sep 2023
Attenuated IL-2 muteins leverage the TCR signal to enhance regulatory T cell homeostasis and response in vivo
Frontiers in Immunology
doi 10.3389/fimmu.2023.1257652
- 736 views
Original Research
Published on 20 Sep 2023
Modulation of intestinal IL-37 expression and its impact on the epithelial innate immune response and barrier integrity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1261666
- 494 views
Methods
Published on 20 Sep 2023
A liquid chromatography-tandem mass spectrometry based method for the quantification of adenosine nucleotides and NAD precursors and products in various biological samples
Frontiers in Immunology
doi 10.3389/fimmu.2023.1250762
- 463 views
Review
Accepted on 18 Sep 2023
T cell Ca 2+ microdomains through the lens of computational modelling
Frontiers in Immunology
doi 10.3389/fimmu.2023.1235737
Original Research
Published on 18 Sep 2023
Soluble biomarkers of HIV-1-related systemic immune activation are associated with high plasma levels of growth factors implicated in the pathogenesis of Kaposi sarcoma in adults
Frontiers in Immunology
doi 10.3389/fimmu.2023.1216480
- 275 views
Review
Accepted on 11 Sep 2023
Interleukin 6: At the interface of human health and disease
Frontiers in Immunology
doi 10.3389/fimmu.2023.1255533
Original Research
Published on 11 Sep 2023
Proteomic aptamer analysis reveals serum biomarkers associated with disease mechanisms and phenotypes of systemic sclerosis
Frontiers in Immunology
doi 10.3389/fimmu.2023.1246777
- 336 views
Original Research
Accepted on 08 Sep 2023
Potential Plasma Biomarkers at Low Altitude for Prediction of Acute Mountain Sickness
Frontiers in Immunology
doi 10.3389/fimmu.2023.1237465
- 159 views
Original Research
Accepted on 07 Sep 2023
Cytokine dysregulation despite immunoglobulin replacement therapy in Common Variable Immunodeficiency (CVID)
Frontiers in Immunology
doi 10.3389/fimmu.2023.1257398
- 169 views
Original Research
Accepted on 06 Sep 2023
Immunotherapy with Stimulator of Interferon Genes and Toll-Like Receptor 9 agonists promote synergistic therapeutic efficacy with suppressed cancer-associated fibroblasts in colon carcinoma
Frontiers in Immunology
doi 10.3389/fimmu.2023.1258691
- 193 views
Review
Published on 01 Sep 2023
IL-32 as a potential biomarker and therapeutic target in skin inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2023.1264236
- 751 views
Original Research
Published on 01 Sep 2023
Interleukin-36γ is causative for liver damage upon infection with Rift Valley fever virus in type I interferon receptor-deficient mice
Frontiers in Immunology
doi 10.3389/fimmu.2023.1194733
- 715 views
Editorial
Published on 31 Aug 2023
Editorial: Role of stem cell derivatives in inflammatory diseases
Frontiers in Immunology
doi 10.3389/fimmu.2023.1275068
- 388 views
Review
Accepted on 30 Aug 2023
The Clinical Relevance of OSM in Inflammatory Diseases: A Comprehensive Review
Frontiers in Immunology
doi 10.3389/fimmu.2023.1239732
- 157 views
Original Research
Published on 29 Aug 2023
Heparins are potent inhibitors of ectonucleotide pyrophosphatase/phospho-diesterase-1 (NPP1) – a promising target for the immunotherapy of cancer
Frontiers in Immunology
doi 10.3389/fimmu.2023.1173634
- 1,100 views